Company Information

CIN
Status
Date of Incorporation
13 May 2011
State / ROC
Ernakulam / ROC Ernakulam
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
51,183,080
Authorised Capital
52,500,000

Directors

Padinjarethalakkal Nanu Ezhuthassan Balaram
Padinjarethalakkal Nanu Ezhuthassan Balaram
Director/Designated Partner
about 2 years ago
Navaneeth Vishnu
Navaneeth Vishnu
Director/Designated Partner
about 6 years ago
Kalathil Sadasivan Pillai
Kalathil Sadasivan Pillai
Director
almost 13 years ago

Past Directors

Ramesh Narayanan
Ramesh Narayanan
Director
almost 13 years ago
Chemmangattuvalappil Balakrishnan Mini
Chemmangattuvalappil Balakrishnan Mini
Director
over 14 years ago

Patents

Novel 2,3 Dihalo 4,4 Bis (Aryl) But 2 Enoic Acid Amides

The present invention relates to novel compounds of formula (I): wherein X, R and Aryl are selected as previously specified. In the present invention novel bisarylated butenoic amides and further derivatives are described as novel medicines. The invention relates to CCK antagonists and opiate agonists and ...

Novel Cholecystokinin Receptor Ligands

The present invention relates to novel compounds of formula (I): wherein X is selected from hydrogen, a halogen, or a substituent. and R is selected from hydrogen, a halogen, phenyl, aryl as specified and Y is selected from H, hydroxy, as specified and R1 is selected from H, methyl, alkyl, C1-18 straight, branc...

A Novel Process For Preparation Of 5 Hydroxy 5 Aryl Pyrrol 2 Ones

ABSTRACT A NOVEL PROCESS FOR PREPARATION OF 5-HYDROXY-5-ARYL-PYRROL-2-ONES AND THEIR INTERMEDIATES The present invention relates to a process for preparation of 5-hydroxy-5-aryl-pyrrol-2-ones of formula I from their intermediate arylated furanone intermediates of formula (II). The present invention relates to a ...

Immunology Of Hydroxy Pyrrolones

The present invention relates to novel compounds of formula (I): (I) wherein X is halogen, alkyl, alkyloxy, alkylcarbonyl, alkyloxycarbonyl, alkenyl, alkenyloxy or alkenylcarbonyl; Y is hydroxy or alkoxy group; R is phenyl, cyanophenyl, or halogenated phenyl; R1 is alkyl, branched alkyl, alkenyl, alkynyl, cyclo...

Registered Trademarks

Pnb Vesper Pnb Vesper Life Sciences

[Class : 35] Wholesale And Retail Outlet For Selling Medicines; Online Wholesale & Retail Store Services Featuring Medicines, Dietary Supplements, Dietetic Preparations, Beauty Implements For Humans, Cosmetic And Beauty Products, Featuring Hygienic Implements For Humans & Physical Therapy Equipment, Medical Apparatus And Allied Products ; Office Functioning For Administratin...

Documents

Optional Attachment-(1)-26102019
Optional Attachment-(2)-26102019
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-26102019
Form DIR-12-26102019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-26102019
Form AOC-4(XBRL)-26102019_signed
List of share holders, debenture holders;-25102019
Form MGT-7-25102019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-26092019
Form DIR-12-26092019_signed
Optional Attachment-(1)-26092019
Form DIR-12-23092019_signed
Evidence of cessation;-23092019
Form ADT-1-12082019_signed
Copy of resolution passed by the company-12082019
Copy of the intimation sent by company-12082019
Copy of written consent given by auditor-12082019
Optional Attachment-(2)-12082019
Optional Attachment-(1)-12082019
Notice of resignation;-12082019
Form DIR-12-12082019_signed
Evidence of cessation;-12082019
Declaration of the appointee director, Managing director, in Form No. DIR-2;-12082019
Form AOC-4(XBRL)-29012019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28012019
Optional Attachment-(2)-28012019
Optional Attachment-(1)-28012019
List of share holders, debenture holders;-29122018
Form MGT-7-29122018_signed
Optional Attachment-(2)-08032018